Investigation Details

The focus of this investigation is whether Apogee and several of its officers and directors may have participated in securities fraud or engaged in other unlawful business practices. A comprehensive evaluation of the Company’s actions is currently underway.

Recent Financial Performance of Apogee (APOG)

On January 7, 2025, Apogee released its financial report for the third quarter of the 2026 fiscal year, detailing several key metrics:

• Sales Revenue: $355.3 million
• Consensus Estimate Miss: Analysts expected $348.6 million

Apogee’s Chief Executive Officer cited several challenges affecting the Company’s performance, including higher aluminum costs, restructuring expenses, and increased health insurance costs.

Following this announcement, the stock price of Apogee (APOG) saw a significant decline, falling $5.18 per share, or 13.89%, to close at $32.11 on January 7, 2026. This reaction underscores the market's sensitivity to financial disclosures amid ongoing investigations.

About Pomerantz LLP

Pomerantz LLP is recognized as a leading law firm in the fields of corporate, securities, and antitrust class litigation. With offices located across cities such as New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, the firm has extensive experience advocating for the rights of investors.

Founded by the late Abraham L. Pomerantz, famously known as the dean of the class action bar, the firm has been at the forefront of securities class actions for over 85 years. Pomerantz is deeply committed to recovering damages for victims of securities fraud, breaches of fiduciary duty, and corporate misconduct.

For more information about their work, visit www.pomlaw.com.

Contact Information

For inquiries related to the investigation, investors may contact: